Cellatoz Therapeutics, Inc. is working on the development and commercialization of RMAT (Regenerative Medicine Advanced Therapy) products including mainly cell therapies in order to provide patients suffering from intractable diseases with fundamental treatments of such diseases employing ‘regenerative therapeutic cells’. In addition, they are conducting exploratory researches on chemical inducer screening, gene delivery methods into target cells and so on in order to secure new technologies on therapeutic cells and cell culture methods for future pipelines.